Ruben Gregory Xavier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ruben Gregory Xavier has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- April Camilla Roslani
Department of Surgery Faculty of Medicine Universiti Malaya Kuala Lumpur Malaysia
3 shared publications Chuey Chuan Tan
Department of Oral-Maxillofacial Surgical and Medical Sciences, University Malaya Medical Centre, Lembah Pantai, 59100, Kuala Lumpur, Malaysia
1 shared publication- Doris Sin-Wen Ng
Department of Obstetrics and Gynaecology, University Malaya Medical Centre, Lembah Pantai, 59100, Kuala Lumpur, Malaysia
1 shared publication - Fei Yee Lee
Clinical Research Centre, Selayang Hospital, Selangor, Malaysia
1 shared publication - Ganesh Vythilingam
Department of Surgery, Faculty of Medicine, University of Malaya, Jalan Universiti, 50603, Kuala Lumpur, Malaysia; Department of Surgery, University Malaya Medical Hospital, Lembah Pantai, 59100, Kuala Lumpur, Malaysia
1 shared publication - Kanesh Kumaran Seevalingam
Department of Surgery, University Malaya Medical Hospital, Lembah Pantai, 59100, Kuala Lumpur, Malaysia
1 shared publication
Latest Publications
- 27 May 2021
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 83 (S3) , 768-775
Pathological Complete Response After Neoadjuvant Therapy in Rectal Adenocarcinoma: a 5-Year Follow-up
Neoadjuvant therapy is the gold standard treatment of locally advanced rectal cancer. It may induce complete sterilization of tumor cell and decreases its local recurrence rate. While 15–20% of patients were found to have pathological complete response (pCR) with combined multimodal therapy, Asian data were generally scarce. pCR rate can indicate the suitability of applying the “watch-and-wait” strategy, which advocates deferment of surgery that can alleviate surgery-associated morbidity.To determine the percentage of pCR of rectal cancer after neoadjuvant therapy. Patients diagnosed with rectal cancer underwent treatment from 2013 to 2017 were retrieved retrospectively. Demographic data, tumor localization, pre- and post-operative pathological reports, neoadjuvant therapy, and pCR status were collected from patients’ records. A total of 242 out of 259 patients were treated with definitive rectal surgery. Mean age was 67.1 years old. Chinese ethnicity and male gender were predominant (n = 131, 54.1% and n = 146, 64.3% respectively). More than half (n = 124, 51.2%) had tumor located at mid or low rectum. Histologically, moderate differentiated adenocarcinoma was predominant (n = 227, 93.8%). Merely half (n = 123, 50.8%) of the patients received neoadjuvant chemoradiation therapy, but only 12 (9.8%) had a pCR. From follow-up on these 12 pCR patients, most had 2-year disease-free survival but 1 (8.3%) of the pCR had distant metastasis within 1-year post-surgery. The pathological complete response rate in our center was lower than reported. Stringent patient selection with close follow-up for patients should be carried out if the “watch-and-wait” strategy is implemented in our population.
- 27 May 2021
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 83 (S3) , 768-775
Pathological Complete Response After Neoadjuvant Therapy in Rectal Adenocarcinoma: a 5-Year Follow-up
Neoadjuvant therapy is the gold standard treatment of locally advanced rectal cancer. It may induce complete sterilization of tumor cell and decreases its local recurrence rate. While 15–20% of patients were found to have pathological complete response (pCR) with combined multimodal therapy, Asian data were generally scarce. pCR rate can indicate the suitability of applying the “watch-and-wait” strategy, which advocates deferment of surgery that can alleviate surgery-associated morbidity.To determine the percentage of pCR of rectal cancer after neoadjuvant therapy. Patients diagnosed with rectal cancer underwent treatment from 2013 to 2017 were retrieved retrospectively. Demographic data, tumor localization, pre- and post-operative pathological reports, neoadjuvant therapy, and pCR status were collected from patients’ records. A total of 242 out of 259 patients were treated with definitive rectal surgery. Mean age was 67.1 years old. Chinese ethnicity and male gender were predominant (n = 131, 54.1% and n = 146, 64.3% respectively). More than half (n = 124, 51.2%) had tumor located at mid or low rectum. Histologically, moderate differentiated adenocarcinoma was predominant (n = 227, 93.8%). Merely half (n = 123, 50.8%) of the patients received neoadjuvant chemoradiation therapy, but only 12 (9.8%) had a pCR. From follow-up on these 12 pCR patients, most had 2-year disease-free survival but 1 (8.3%) of the pCR had distant metastasis within 1-year post-surgery. The pathological complete response rate in our center was lower than reported. Stringent patient selection with close follow-up for patients should be carried out if the “watch-and-wait” strategy is implemented in our population.
- Open Access
- 1 March 2021
- Published by Elsevier in Asian Journal of Surgery
- Vol. 44 (3) , 560-561
Pre-surgical COVID-19 swabs in surgical patients: An institutional experience in a middle income country
- 1 March 2021
- Published by Elsevier in Asian Journal of Surgery
- Vol. 44 (3) , 560-561
Open AccessPre-surgical COVID-19 swabs in surgical patients: An institutional experience in a middle income country
- Open Access
- 1 January 2021
- Published by Elsevier in Asian Journal of Surgery
- Vol. 44 (1) , 404-406
Focused surgical pandemic response in a Malaysian hybrid COVID-19 hospital
- 1 January 2021
- Published by Elsevier in Asian Journal of Surgery
- Vol. 44 (1) , 404-406
Open AccessFocused surgical pandemic response in a Malaysian hybrid COVID-19 hospital